Top Markets
#1 DogBull DogBull +106.47%
#2 Siacoin Siacoin +51.39%
#3 ADO Protocol ADO Protocol +51.06%
#4 The Bitcoin Bull The Bitcoin Bull +43.52%
#5 MarsCoin MarsCoin +34.59%
#6 龙虾 (Lobster) 龙虾 (Lobster) +29.50%
#7 Glidr Glidr +25.57%
#8 Ontology Gas Ontology Gas +21.33%
#9 UnifAI Network UnifAI Network +19.84%
#10 Falcon Finance Falcon Finance +17.84%
Coin of the day
DogBull DogBull
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
ShanXi C&Y Pharmaceutical Group Co., Ltd. ShanXi C&Y Pharmaceutical Group Co., Ltd.

ShanXi C&Y Pharmaceutical Group Co., Ltd.

300254
Clasificación en acciones #15740
ShanXi C&Y Pharmaceutical Group Co., Ltd. is a global pharmaceutical enterprise... ShanXi C&Y Pharmaceutical Group Co., Ltd. is a global pharmaceutical enterprise dedicated to the research, development, production, and distribution of a diverse range of medicines. Its operations span key markets including China, the United States, and Hong Kong, alongside other international regions. The company's extensive product catalog features specialized solutions for maternal and infant care, urological health, and infectious diseases, as well as traditional Chinese remedies and dermatological treatments. Additionally, it diversifies its offerings with tea bag products. Founded in 2005, the organization underwent a name change in September 2014, evolving from Shanxi C&Y Pharmaceutical Co., Ltd. to its current designation. ShanXi C&Y Pharmaceutical Group Co., Ltd. maintains its corporate headquarters in Shanghai, China.
Precio por acción
$1.30
Capitalización bursátil
$333.97M
Cambio (1 día)
0.45%
Cambio (1 año)
-19.21%
País
CN
Comercio ShanXi C&Y Pharmaceutical Group Co., Ltd. (300254)

Categoría

Healthcare
Ganancias de ShanXi C&Y Pharmaceutical Group Co., Ltd. (300254)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di ShanXi C&Y Pharmaceutical Group Co., Ltd., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de ShanXi C&Y Pharmaceutical Group Co., Ltd. desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
- -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
- -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
- -
JP
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
$1.76B -
IN
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
- -
CH